Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
1,220.60
-49.70 (-3.91%)
Aug 1, 2025, 3:30 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Global Generics | 245.45B | Log In | Log In | Log In | Log In | Upgrade |
Global Generics Growth | 14.82% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Services and Active Ingredients | 29.80B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Services and Active Ingredients Growth | 2.52% | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.91B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 28.53% | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Products | - | Log In | Log In | Log In | Log In | Upgrade |
Proprietary Products Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 3.91B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 28.53% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Other | 72.83B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 7.94% | Log In | Log In | Log In | Log In | Upgrade |
United States | 135.57B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 27.07% | Log In | Log In | Log In | Log In | Upgrade |
India | 48.47B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | -4.01% | Log In | Log In | Log In | Log In | Upgrade |
Russia | 22.30B | Log In | Log In | Log In | Log In | Upgrade |
Russia Growth | 5.05% | Log In | Log In | Log In | Log In | Upgrade |
Other | 72.83B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 7.94% | Log In | Log In | Log In | Log In | Upgrade |